XML 29 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class B Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019         $ 160,555
Balance (in shares) at Dec. 31, 2019         84,201,570
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Series E convertible preferred stock, net of issuance costs         $ 35,259
Issuance of Series E convertible preferred stock, net of issuance costs (in shares)         6,587,698
Balance at Dec. 31, 2020         $ 195,814
Balance (in shares) at Dec. 31, 2020         90,789,268
Balance at Dec. 31, 2019 $ 1 $ 0 $ 10,530 $ (135,630) $ (125,099)
Balance (in shares) at Dec. 31, 2019 5,263,403 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ 0 $ 0 0 (36,613) (36,613)
Issuance of series E convertible preferred stock, net of issuance costs $ 0 $ 0 0 0 0
Issuance of series E convertible preferred stock, net of issuance costs (in shares) 0 0      
Common stock issued upon exercise of stock options $ 0 $ 0 63 0 63
Common stock issued upon exercise of stock options (in shares) 114,884 0      
Stock-based compensation $ 0 $ 0 1,924 0 1,924
Balance at Dec. 31, 2020 $ 1 $ 0 12,517 (172,243) (159,725)
Balance (in shares) at Dec. 31, 2020 5,378,287 0      
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Series E convertible preferred stock, net of issuance costs         $ (4)
Issuance of Series E convertible preferred stock, net of issuance costs (in shares)         0
Conversion of the convertible preferred stock into Class A and B common stock         $ (195,810)
Conversion of the convertible preferred stock into Class A and B common stock (in shares)         (90,789,268)
Balance at Dec. 31, 2021         $ 0
Balance (in shares) at Dec. 31, 2021         0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ 0 $ 0 0 (94,989) $ (94,989)
Issuance of series E convertible preferred stock, net of issuance costs $ 0 $ 0 0 0 0
Issuance of series E convertible preferred stock, net of issuance costs (in shares) 0 0      
Common stock issued upon exercise of stock options and vesting of restricted stock units $ 0 $ 0 5,618 0 5,618
Common stock issued upon exercise of stock options and vesting of restricted stock units (in shares) 2,935,595 0      
Conversion of the convertible preferred stock into common stock $ 5 $ 2 195,803 0 195,810
Conversion of the convertible preferred stock into common stock (in shares) 52,466,941 19,937,500      
Net equity infusion from the Business Combination $ 6 $ 0 501,164 0 501,170
Net equity infusion from the Business Combination (in shares) 56,708,872 0      
Majelac Technologies LLC Acquisition $ 0 $ 0 4,232 0 4,232
Majelac Technologies LLC Acquisition (in shares) 535,715 0      
Stock-based compensation $ 0 $ 0 24,918 0 24,918
Balance at Dec. 31, 2021 $ 12 $ 2 744,252 (267,232) 477,034
Balance (in shares) at Dec. 31, 2021 118,025,410 19,937,500      
Balance at Dec. 31, 2022         $ 0
Balance (in shares) at Dec. 31, 2022         0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ 0 $ 0 0 (132,442) $ (132,442)
Common stock issued upon exercise of stock options and vesting of restricted stock units $ 0 $ 0 2,757 0 2,757
Common stock issued upon exercise of stock options and vesting of restricted stock units (in shares) 1,921,824 0      
Majelac Technologies LLC Acquisition $ 0 $ 0 151 0 151
Majelac Technologies LLC Acquisition (in shares) 59,523 0      
Stock-based compensation $ 0 $ 0 11,206 0 11,206
Balance at Dec. 31, 2022 $ 12 $ 2 $ 758,366 $ (399,674) $ 358,706
Balance (in shares) at Dec. 31, 2022 120,006,757 19,937,500